J&J aims to 'save legs, change lives' with new peripheral artery disease awareness effort
$ 13.99 · 4.5 (738) · In stock
Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S. | Peripheral artery disease, or PAD, is a leading cause of amputations in the U.S. But the disease can be silent, so millions of Americans—especially Black Americans—don’t know they have it until it’s too late. Johnson & Johnson’s Janssen unit is hoping to change that with a new awareness initiative.
Revolutionary Solutions: Improving Outcomes for Peripheral Artery
Amy Carmen-Hall on LinkedIn: National Peripheral Artery Disease
Janssen's Save Legs. Change Lives.™ is Creating a More Equitable
Education Save Legs. Change Lives™
New Janssen initiative aims to advance equitable care and address
Jon Bloom, M.D. on LinkedIn: Video Severed: Diabetes Denial and
Save Legs. Change Lives.™ Paves the Way for Change
Revolutionary Solutions: Improving Outcomes for Peripheral Artery
About Us Save Legs. Change Lives™
Save Legs. Change Lives.™ Paves the Way for Change
The Janssen Pharmaceutical Companies of Johnson & Johnson on
Revolutionary Solutions: Improving Outcomes for Peripheral Artery
Save Legs. Change Lives.™ Paves the Way for Change
Editor's Choice -- European Society for Vascular Surgery (ESVS